According to filings with the U.S. Securities and Exchange Commission, Alleviant Medical is raising $88,334,339.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Adam Berman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Alleviant Medical
Alleviant Medical is a medical device company developing potential therapies for congestive heart failure. Alleviant Medical has developed a novel transcatheter device for the creation of a durable interatrial shunt without requiring a permanent implant. A breakthrough device for treating heart failure with preserved ejection fraction (HFpEF).

To learn more about Alleviant Medical, visit http://www.alleviantmedical.com/

Contact:
Adam Berman, Chief Executive Officer
857-776-2154
https://www.linkedin.com/in/adamlberman/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.